Mathieu Porte

Title: The Innovations of Mathieu Porte

Introduction

Mathieu Porte is an accomplished inventor based in Lingolsheim, France. He has made significant contributions to the field of gene delivery through his innovative research and patents. His work focuses on enhancing the efficiency of nucleic acid transfection while minimizing cytotoxicity.

Latest Patents

Mathieu Porte holds a patent for "Compositions for transfecting a nucleic acid molecule into a cell comprising benzo-fused heterocyclic compounds grafted to a cationic polymer, and their applications." This patent describes compositions that include at least one benzimidazole or benzotriazole compound, which is substituted at a ring nitrogen by a graft cationic polymer. The compositions are designed for in vitro or ex vivo gene delivery, achieving high transfection efficiency with reduced cytotoxicity.

Career Highlights

Mathieu Porte is currently associated with Sartorius Polyplus, where he continues to advance his research in the field of gene therapy. His innovative approaches have positioned him as a key figure in the development of effective transfection methods.

Collaborations

Mathieu collaborates with notable colleagues, including Fanny Premartin and Fabrice Stock. Their combined expertise contributes to the ongoing advancements in their research projects.

Conclusion

Mathieu Porte's contributions to the field of gene delivery through his innovative patents and collaborations highlight his role as a leading inventor in this area. His work continues to pave the way for advancements in biotechnology and medicine.